Earnings History Data for Anika Therapeutics Inc. (ANIK) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Anika Therapeutics Inc.
Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative cartilage repair. Anika's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31-10-2024 | PM | ANIK | Anika Therapeutics Inc. | 362.82 | -0.44 | 0.01 | 0.00 | Anika Therapeutics Non-GAAP EPS of -$0.25, revenue of $38.8M [10/31/2024 7:46 AM] |
17.26 | -7.42 (-30.06%) |
24.68 | 0.0 (0.00%) |
16.00 - 29.11 | 387,151 | 50,000 | 9,846 | ||
|
||||||||||||||||||
| 08-08-2024 | AH | ANIK | Anika Therapeutics Inc. | 386.58 | N/A | -0.06 | -0.06 | Anika Therapeutics Non-GAAP EPS of $0.17 misses by $0.03, revenue of $41.9M beats by $1.13M [8/8/2024 4:33 PM] |
25.55 | -0.13 (-0.51%) |
25.68 | 0.0 (0.00%) |
16.54 - 29.11 | 41,178 | 40,000 | 1,898 | ||
| 08-05-2024 | AH | ANIK | Anika Therapeutics Inc. | 413.72 | 0.09 | 0.13 | -0.36 | Anika Therapeutics Non-GAAP EPS of $0.09 beats by $0.17, revenue of $40.5M beats by $1.36M [5/8/2024 4:15 PM] |
25.25 | -3.22 (-11.31%) |
28.00 | -0.47 (-1.65%) |
16.54 - 28.67 | 150,633 | 60,000 | 2,050 | ||
| 13-03-2024 | AH | ANIK | Anika Therapeutics Inc. | 377.59 | 0.05 | -0.15 | -0.21 | Anika Therapeutics Non-GAAP EPS of $0.05 beats by $0.28, revenue of $42.97M beats by $1.57M [3/13/2024 4:22 PM] |
24.48 | -0.91 (-3.60%) |
27.00 | 1.60 (6.30%) |
16.54 - 29.25 | 196,084 | 100,000 | 49,098 | ||
| 02-11-2023 | AH | ANIK | Anika Therapeutics Inc. | 285.31 | N/A | -0.26 | -0.05 | Anika Therapeutics Non-GAAP EPS of $0.00 beats by $0.35, revenue of $41.5M beats by $3.23M [11/2/2023 4:32 PM] |
21.10 | 2.11 (11.11%) |
21.62 | 2.63 (13.85%) |
16.54 - 32.51 | 225,908 | 90,000 | 936 | ||
| 08-08-2023 | AH | ANIK | Anika Therapeutics Inc. | 322.22 | -0.06 | -0.27 | -0.12 | Anika Therapeutics beats Q2 top and bottom line estimates; updates FY23 outlook [8/8/2023 5:31 PM] |
19.98 | -1.07 (-5.11%) |
22.05 | 1.00 (4.75%) |
19.55 - 32.51 | 189,330 | 100,000 | 2,248 | ||
| 09-05-2023 | AH | 4:05 PM ET (May 9) |
ANIK | Anika Therapeutics Inc. | 378.55 | -0.36 | -0.29 | -0.11 | Anika Therapeutics GAAP EPS of -$0.71 misses by $0.37, revenue of $37.9M beats by $0.54M [5/9/2023 4:35 PM] |
25.25 | -0.04 (-0.16%) |
25.29 | 0.0 (0.00%) |
20.12 - 32.51 | 89,476 | 70,000 | 1,817 | |
| 06-03-2023 | AH | 4:05 PM ET (Mar 6) |
ANIK | Anika Therapeutics Inc. | 464.15 | -0.21 | -0.15 | -0.23 | Anika Therapeutics Non-GAAP EPS of -$0.21 beats by $0.01, revenue of $39.6M beats by $1.89M, guidance below consensus [3/6/2023 4:09 PM] |
26.03 | -2.84 (-9.84%) |
28.87 | 0.0 (0.00%) |
19.95 - 32.51 | 369,843 | 80,000 | 925 | |
| 08-11-2022 | AH | 4:05 PM ET (Nov 8) |
ANIK | Anika Therapeutics Inc. | 420.92 | -0.05 | -0.18 | 0.05 | Anika Therapeutics Non-GAAP EPS of -$0.05 beats by $0.18, revenue of $40.3M beats by $2.71M [11/8/2022 4:40 PM] |
29.77 | 2.40 (8.77%) |
27.37 | 0.0 (0.00%) |
19.95 - 41.70 | 162,747 | 110,000 | 1,795 | |
| 03-08-2022 | AH | 4:05 PM ET (Aug 3) |
ANIK | Anika Therapeutics Inc. | 325.64 | -0.12 | -0.19 | 0.09 | Anika Therapeutics Non-GAAP EPS of -$0.12 beats by $0.09, revenue of $39.7M beats by $1.85M [8/3/2022 4:35 PM] |
22.91 | -1.76 (-7.15%) |
24.68 | 0.0 (0.00%) |
19.95 - 45.81 | 175,128 | 50,000 | 1,939 | |
| 05-05-2022 | AH | 4:05 PM ET (May 5) |
ANIK | Anika Therapeutics Inc. | 313.76 | -0.11 | -0.24 | 0.06 | Anika Therapeutics Non-GAAP EPS of -$0.11 beats by $0.20, revenue of $36.69M beats by $3.76M [5/5/2022 4:54 PM] |
21.06 | 0.50 (2.43%) |
20.56 | 0.0 (0.00%) |
19.95 - 48.37 | 247,448 | 80,000 | 472 | |
| 08-03-2022 | AH | 4:05 PM ET (Mar 8) |
ANIK | Anika Therapeutics Inc. | 448.41 | -0.23 | -0.07 | 0.12 | Anika Therapeutics Non-GAAP EPS of -$0.23 misses by $0.02, revenue of $35.82M beats by $3.77M [3/8/2022 4:28 PM] |
25.32 | -5.28 (-17.25%) |
30.60 | 0.0 (0.00%) |
25.00 - 48.37 | 69,667 | 70,000 | 1,029 | |
|
||||||||||||||||||
| 04-11-2021 | AH | 4:05 PM ET (Nov 4) |
ANIK | Anika Therapeutics Inc. | 619.61 | 0.05 | 0.08 | -0.45 | Anika Therapeutics EPS beats by $0.06, beats on revenue [11/4/2021 4:46 PM] |
45.10 | 1.78 (4.10%) |
43.32 | 0.0 (0.00%) |
32.30 - 48.37 | 38,384 | 50,000 | 316 | |
|
||||||||||||||||||
| 05-08-2021 | AH | 4:05 PM ET (Aug 5) |
ANIK | Anika Therapeutics Inc. | 588.03 | 0.09 | 0.04 | 0.09 | Anika Therapeutics EPS beats by $0.12, beats on revenue [8/5/2021 5:18 PM] |
40.45 | -0.64 (-1.56%) |
41.09 | 0.0 (0.00%) |
32.04 - 48.37 | 43,344 | 50,000 | 593 | |
| 06-05-2021 | AH | 4:05 PM ET (May 6) |
ANIK | Anika Therapeutics Inc. | 584.87 | 0.06 | 0.01 | 0.45 | Anika Therapeutics EPS beats by $0.10, beats on revenue [5/6/2021 4:22 PM] |
41.99 | 1.21 (2.97%) |
41.43 | 0.0 (0.00%) |
27.54 - 47.48 | 90,072 | 90,000 | 505 | |
|
||||||||||||||||||
| 04-03-2021 | AH | 4:05 PM ET (Mar 4) |
ANIK | Anika Therapeutics Inc. | 542.99 | 0.12 | 0.11 | 0.43 | Anika Therapeutics EPS beats by $0.01, misses on revenue [3/4/2021 4:21 PM] |
34.92 | -3.21 (-8.42%) |
38.13 | 0.0 (0.00%) |
22.01 - 47.48 | 196,886 | 161,657 | 1,699 | |
| 04-11-2020 | AH | 4:05 PM ET (Nov 4) |
ANIK | Anika Therapeutics Inc. | 470.55 | -0.45 | 0.13 | 0.64 | Anika Therapeutics EPS beats by $0.06, beats on revenue [11/4/2020 4:24 PM] |
33.92 | -2.85 (-7.75%) |
36.77 | 0.0 (0.00%) |
22.01 - 67.09 | 142,928 | 96,091 | 2,828 | |
|
|
||||||||||||||||||
| 30-07-2020 | AH | 4:05 PM ET (Jul 30) |
ANIK | Anika Therapeutics Inc. | 500.91 | 0.09 | -0.21 | 0.67 | Anika Therapeutics EPS beats by $0.23, beats on revenue [7/30/2020 4:08 PM] |
36.39 | -0.78 (-2.10%) |
37.00 | -0.17 (-0.46%) |
22.01 - 75.72 | 70,405 | 96,846 | 1,744 | |
|
|
||||||||||||||||||